Inventor · disambiguated record
Alexandra Kuznetsova
Also filed as: Kuznetsova Alexandra
4 granted patents·4 pending applications·7 citations·filing 2017–2022
68Inventor score
Top patents by PatentIndex Score
8 records- 0177US10322128B2Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitorsFELICITEX THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·3 cites·20 claims
- 0274US10314843B2Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosisFELICITEX THERAPEUTICS INC·Filed 2017·Granted Jun 11, 2019·2 cites·20 claims
- 0371US11202779B2Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitorsFELICITEX THERAPEUTICS INC·Filed 2019·Granted Dec 21, 2021·1 cites·9 claims
- 0465US2022110940A1Combinations for the treatment of neoplasms using quiescent cell targeting with egfr inhibitorsFELICITEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0565US2022110941A1Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosisFELICITEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0657US10577365B2Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinasesFELICITEX THERAPEUTICS INC·Filed 2017·Granted Mar 3, 2020·1 cites·14 claims
- 0753US2019290651A1Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosisFELICITEX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0850US2023226061A1Combination cancer therapy with dyrk1 inhibitors and inhibitors of the ras-raf-mek-erk (mapk) pathwayFELICITEX THERAPUETICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexandra Kuznetsova files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →